BOUT Performance — Innovator IBD(R) Breakout Opportunities ETF
Data updated: 2026-03-27
BOUT returned +6.63% year to date and −4.17% over one year to Jan 2026. Annualised returns are +8.64% over 3 years and +4.01% over 5 years. The fund trailed its US Multi-Cap Growth category average: $100 invested three years ago grew to $128, against $160 for the category, and to $96 over one year, against $113. Volatility over the past three years was 16.89% a year. In the 12 months to Jan 2026 the fund took in a net $79K, and assets reached $13.55M.
BOUT Growth of $100
What $100 invested in Innovator IBD(R) Breakout Opportunities ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Growth category average over the same months.
| Period | BOUT | Category average |
|---|---|---|
| 1 year (Feb 2025 – Jan 2026) | $96 | $113 |
| 3 years (Feb 2023 – Jan 2026) | $128 | $160 |
| 5 years (Feb 2021 – Jan 2026) | $122 | $145 |
| Since data start (Feb 2020 – Jan 2026) | $186 | $204 |
BOUT Trailing Returns
Total returns to Jan 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.63% |
| 1 year | −4.17% |
| 3 years (annualised) | +8.64% |
| 5 years (annualised) | +4.01% |
BOUT Annual Returns
Calendar-year total returns of Innovator IBD(R) Breakout Opportunities ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jan) | +6.63% |
| 2025 | −6.84% |
| 2024 | +18.87% |
| 2023 | +13.05% |
| 2022 | −22.34% |
| 2021 | +23.03% |
| 2020 (Feb–Dec) | +46.01% |
BOUT Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.6% | — | — | — | — | — | — | — | — | — | — | — |
| 2025 | +3.7% | −5.4% | −5.3% | −7.4% | +4.5% | +4.6% | +2.1% | +1.0% | +3.1% | −3.3% | −0.7% | −2.8% |
| 2024 | −0.1% | +7.2% | +2.8% | −7.6% | +4.7% | −0.9% | +3.5% | +1.5% | −0.1% | −0.1% | +11.7% | −3.6% |
| 2023 | +4.1% | −2.1% | +3.1% | −1.1% | −4.2% | +9.3% | +3.4% | −5.7% | −3.4% | −4.4% | +7.0% | +7.9% |
| 2022 | −10.3% | +5.6% | +3.3% | −7.9% | −1.1% | −12.7% | +5.9% | −2.7% | −9.2% | +9.2% | +2.2% | −4.2% |
| 2021 | +4.8% | +2.9% | −2.6% | +4.3% | −4.7% | +1.4% | +2.7% | +3.7% | −3.6% | +6.8% | −0.5% | +6.6% |
| 2020 | — | −9.1% | −7.7% | +12.9% | +7.6% | +1.6% | +8.6% | +1.3% | −3.2% | −0.8% | +19.6% | +11.7% |
BOUT Risk
Risk measures from monthly returns over Feb 2023 – Jan 2026.
- 3-year volatility (annualised): 16.89%
- 3-year Sharpe ratio: 0.24 (vs 4.5% risk-free rate)
- Best month: +11.69% (Nov 2024)
- Worst month: −7.62% (Apr 2024)
BOUT Fund Flows
Monthly money in and out of Innovator IBD(R) Breakout Opportunities ETF, from SEC Form N-PORT.
- 12-month net flow: $79K
- 12-month gross sales (incl. reinvestments): $3.8M
- Sales ÷ redemptions: 1.02×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jan 2026 | $1.9M | $0 | $1.9M |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $1.9M | $1.9M | $0 |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $0 | $0 | $0 |
| Jun 2025 | $0 | $1.8M | −$1.8M |
| May 2025 | $0 | $0 | $0 |
| Apr 2025 | $0 | $0 | $0 |
| Mar 2025 | $0 | $0 | $0 |
| Feb 2025 | $0 | $0 | $0 |
BOUT Assets Under Management
Net assets of Innovator IBD(R) Breakout Opportunities ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-01-31 | $13.55M |
| 2025-10-31 | $11.32M |
| 2025-07-31 | $11.25M |
| 2025-04-30 | $11.76M |
| 2025-01-31 | $14.19M |
| 2024-10-31 | $12.79M |
| 2024-07-31 | $12.63M |
| 2024-04-30 | $13.46M |
| 2024-01-31 | $13.22M |
| 2023-10-31 | $11.62M |
| 2023-07-31 | $13.34M |
| 2023-04-30 | $13.87M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.